Retrograde Tibial Access for Endovascular Treatment of Femoropopliteal Occlusions: Is it a Safe Strategy?

Endovascular recanalization of femoropopliteal occlusions continues to be one of the initial therapeutic strategies to treat this pathology. 

Acceso retrógrado mediante la arteria tibial para el tratamiento de oclusiones en territorio femoropoplíteo: ¿es una estrategia segura?

The anterograde approach via the common femoral is the most frequently used. However, it is not always viable, especially in long occlusions with severe calcification or when the femoral artery cannot be reached. In these cases, the retrograde approach represents a safe and effective strategy. 

The aim of this retrospective, single center study was to assess the safety, efficacy and feasibility of retrograde crossing of femoropopliteal occlusions with tibial access after failed anterograde approach. 

Primary efficacy endpoint was retrograde crossing success rate. secondary efficacy endpoint was technical success rate. Primary safety endpoint was the rate of acute (≤30 days) access site-specific complications. 

Secondary safety endpoints included the rate of major adverse cardiovascular events (MACE) at 30 days (30-day MACE) and the rate of acute (≤30 days) intervention-specific complications.

Primary feasibility endpoint was rate of successful cannulation and sheath introduction. Secondary feasibility endpoints included the cannulation time and the time for hemostasis.

Read also: PICCOLETO-II: balones liberadores de droga en vasos pequeños.

From 2015 to 2022 the study looked at 152 patients. Mean age was 74 and 50.7% were men. The most frequent clinical presentation was resting pain in 67.8% (Rutherford IV), followed by Rutherford III in 22.4% of patients. Mean lesion length was 25 cm, and 45% of cases presented PACSS calcification grade III followed by grade IV in 43%. The proximal tract of the anterior tibial artery was the most used (60.5%), and sheath inductor and cannulation (4Fr in 50.7%) were successful in all cases.  

Rate of retrograde crossing of femoropopliteal occlusions was 94%. As regards Access site related complications within 30 days, these were found in 4.6% of patients. Specific complications associated to the intervention happened in 12.5% of cases. MACE rate was 3.3% and MALE rate (major adverse limb events) was 2%. 

Conclusion

Retrograde crossing of femoropopliteal occlusions with tibial access after anterograde failed approach is feasible, safe and effective. It could be an interesting alternative to combine both these approaches. This calls for further prospective, randomized and multicenter studies with long term follow up. 

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the editorial board of SOLACI.org.

Original Title: Endovascular treatment of femoro‐popliteal occlusions with retrograde tibial access after failure of the antegrade approach.

Reference: Roberto Minici MD et al Catheter Cardiovasc Interv. 2023;1–12.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

New Carotid PCI All-in-One System

Carotid stenting is equivalent to carotid endarterectomy in terms of major adverse events (death, AMI, and stroke). However, it entails higher risk of minor...

PERFORMANCE II Trial: Safety and Efficacy of the New NeuroGuard Carotid Stent System

The percutaneous treatment of carotid artery disease through stenting (CAS) for the prevention of cerebrovascular disease has proven to be an effective alternative compared...

Trends in the Treatment of Critical Lower Limb Ischemia

Approximately 25% of patients with critical lower limb ischemia (CLLI) face amputation within the first year after diagnosis (according to statistics from the United...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

ROLLER COASTR-EPIC22: Comparison of Plaque Modification Techniques in Severely Calcified Coronary Lesions

The presence of coronary calcium significantly limits the success of percutaneous coronary interventions (PCI), primarily due to suboptimal stent expansion. This can lead to...

Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation

Mitral regurgitation (MR) is a common condition, with approximately 3.5% prevalence in individuals under 65, increasing to 7.7% in those over 75. It can...